About Ventria Bioscience

Ventria Bioscience is the first company to commercialize recombinant proteins derived from a plant-based manufacturing system. Ventria’s technology platform ExpressTec is a safe, affordable and sustainable manufacturing technology that achieves recombinant protein yield that is many times higher than alternative systems. This advantage means Ventria’s products are accessible to a global customer base.

Ventria has commercialized nine products and is targeting three markets:

• Human Health
• Cell-based biomanufacturing
• Zoonotic Disease